Skip Nav Destination
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
Issue Archive
September 12 2013
Table of Contents
INSIDE BLOOD
BLOOD WORK
PLENARY PAPER
REVIEW ARTICLE
REVIEW SERIES
CLINICAL TRIALS AND OBSERVATIONS
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
Clinical Trials & Observations
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
Alessandra Ferrajoli,Tait D. Shanafelt,Cristina Ivan,Masayoshi Shimizu,Kari G. Rabe,Nazila Nouraee,Mariko Ikuo,Asish K. Ghosh,Susan Lerner,Laura Z. Rassenti,Lianchun Xiao,Jianhua Hu,James M. Reuben,Steliana Calin,M. James You,John T. Manning,William G. Wierda,Zeev Estrov,Susan O’Brien,Thomas J. Kipps,Michael J. Keating,Neil E. Kay,George A. Calin
MYELOID NEOPLASIA
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Joshua J. Oaks,Ramasamy Santhanam,Christopher J. Walker,Steve Roof,Jason G. Harb,Greg Ferenchak,Ann-Kathrin Eisfeld,James R. Van Brocklyn,Roger Briesewitz,Sahar A. Saddoughi,Kyosuke Nagata,Robert Bittman,Michael A. Caligiuri,Omar Abdel-Wahab,Ross Levine,Ralph B. Arlinghaus,Alfonso Quintas-Cardama,John M. Goldman,Jane Apperley,Alistair Reid,Dragana Milojkovic,Mark T. Ziolo,Guido Marcucci,Besim Ogretmen,Paolo Neviani,Danilo Perrotti
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Corien L. Eckhardt,for the INSIGHT Study Group,Alice S. van Velzen,for the INSIGHT Study Group,Marjolein Peters,for the INSIGHT Study Group,Jan Astermark,for the INSIGHT Study Group,Paul P. Brons,for the INSIGHT Study Group,Giancarlo Castaman,for the INSIGHT Study Group,Marjon H. Cnossen,for the INSIGHT Study Group,Natasja Dors,for the INSIGHT Study Group,Carmen Escuriola-Ettingshausen,for the INSIGHT Study Group,Karly Hamulyak,for the INSIGHT Study Group,Daniel P. Hart,for the INSIGHT Study Group,Charles R. M. Hay,for the INSIGHT Study Group,Saturnino Haya,for the INSIGHT Study Group,Waander L. van Heerde,for the INSIGHT Study Group,Cedric Hermans,for the INSIGHT Study Group,Margareta Holmström,for the INSIGHT Study Group,Victor Jimenez-Yuste,for the INSIGHT Study Group,Russell D. Keenan,for the INSIGHT Study Group,Robert Klamroth,for the INSIGHT Study Group,Britta A. P. Laros-van Gorkom,for the INSIGHT Study Group,Frank W. G. Leebeek,for the INSIGHT Study Group,Ri Liesner,for the INSIGHT Study Group,Anne Mäkipernaa,for the INSIGHT Study Group,Christoph Male,for the INSIGHT Study Group,Evelien Mauser-Bunschoten,for the INSIGHT Study Group,Maria G. Mazzucconi,for the INSIGHT Study Group,Simon McRae,for the INSIGHT Study Group,Karina Meijer,for the INSIGHT Study Group,Michael Mitchell,for the INSIGHT Study Group,Massimo Morfini,for the INSIGHT Study Group,Marten Nijziel,for the INSIGHT Study Group,Johannes Oldenburg,for the INSIGHT Study Group,Kathelijne Peerlinck,for the INSIGHT Study Group,Pia Petrini,for the INSIGHT Study Group,Helena Platokouki,for the INSIGHT Study Group,Sylvia E. Reitter-Pfoertner,for the INSIGHT Study Group,Elena Santagostino,for the INSIGHT Study Group,Piercarla Schinco,for the INSIGHT Study Group,Frans J. Smiers,for the INSIGHT Study Group,Berthold Siegmund,for the INSIGHT Study Group,Annarita Tagliaferri,for the INSIGHT Study Group,Thynn T. Yee,for the INSIGHT Study Group,Pieter Willem Kamphuisen,for the INSIGHT Study Group,Johanna G. van der Bom,for the INSIGHT Study Group,Karin Fijnvandraat,for the INSIGHT Study Group
TRANSPLANTATION
HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion
Sanja Stevanović,Cornelis A. M. van Bergen,Simone A. P. van Luxemburg-Heijs,Boris van der Zouwen,Ekaterina S. Jordanova,Alwine B. Kruisselbrink,Marian van de Meent,Jessica C. Harskamp,Frans H. J. Claas,Erik W. A. Marijt,Jaap Jan Zwaginga,Constantijn J. M. Halkes,Inge Jedema,Marieke Griffioen,J. H. Frederik Falkenburg
CORRESPONDENCE
ANKRD26-related thrombocytopenia and myeloid malignancies
Patrizia Noris,Remi Favier,Marie-Christine Alessi,Amy E. Geddis,Shinji Kunishima,Paula G. Heller,Paola Giordano,Karen Y. Niederhoffer,James B. Bussel,Gian Marco Podda,Nicola Vianelli,Rogier Kersseboom,Alessandro Pecci,Chiara Gnan,Caterina Marconi,Anne Auvrignon,William Cohen,Jennifer C. Yu,Akihiro Iguchi,Allison Miller Imahiyerobo,Francoise Boehlen,Dorsaf Ghalloussi,Daniela De Rocco,Pamela Magini,Elisa Civaschi,Ginevra Biino,Marco Seri,Anna Savoia,Carlo L. Balduini
Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia
Takashi Satoh,Koji Miyazaki,Asako Shimohira,Naoki Amano,Yuka Okazaki,Tetsuya Nishimoto,Tohru Akahoshi,Shinichi Munekata,Yuhsaku Kanoh,Yasuo Ikeda,Masaaki Higashihara,Shinichiro Takahashi,Masataka Kuwana
-
Cover Image
Cover Image
Multicolor immunofluorescent staining for CD3 (clone PS1, IgG2a + IgG2a ALEXA 546) (red), CD8 (clone 4B11, IgG2b + IgGb ALEXA 647) (blue), and HLA class II (clone CR3/43, IgG1 + IgG1 ALEXA 488) (green) was performed on colonic biopsy from patient-2 obtained at the time of GVHD diagnosis after CD4+ DLI. Double CD3+CD8+ cells (purple) were defined as CD8+ T-cells, whereas CD3+CD8- expressing cells (red) were defined as CD4+ T-cells. Images were captured with a confocal laser scanning microscope (LSM510, Zeiss, Sliedrecht, The Netherlands) (×200 magnification) (supplemental Methods). See the article by Stevanović et al on page 1963.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals